Abstract
With the loss of estrogen that occurs with menopause, physiologic and structural changes occur within the vulvovaginal mucosa that lead to a condition commonly called atrophic vaginitis. Although mild genital changes occur in most women, 10-47% of postmenopausal women will develop one or more debilitating symptoms that include vulvovaginal dryness, dyspareunia, vulvar itching or pain, recurrent urinary tract infections, as well as abnormal vaginal discharge. Topical estrogen replacement therapies reverse these mucosal changes and are effective treatments for the symptoms of atrophic vaginitis. Vaginal moisturizers and lubricants also provide symptomatic relief for vaginal dryness and dyspareunia, respectively.
Original language | English (US) |
---|---|
Pages (from-to) | 514-522 |
Number of pages | 9 |
Journal | Dermatologic Therapy |
Volume | 23 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2010 |
Keywords
- aging
- atrophic vagina
- atrophic vaginitis
- estrogen deficiency
- estrogen replacement therapy
- menopause
- perimenopause
- vaginitis
- vulvar diseases
ASJC Scopus subject areas
- Dermatology